Episode 362
How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.
July 17, 202512m 32s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss summertime illnesses and key insights from a recent diagnostic investment event. Together, they explore:
Common summertime illnesses, along with tips for prevention.
- How investment in diagnostic tools influences innovation in the laboratory.
- The potential impact of growing interest in AI investments.
- The investment interest in liquid biopsy and its potential implications for clinical decision-making.
- How AI development may accelerate adoption of mass spectrometry, proteomics, and similar advancements in clinical laboratories.
Topics
laboratory medicinehealthcareanswers from the labmayo clinic laboratorieslabmayo clinicclinicalDLMPMoricePritt